Another amazing presence for Wyss Zurich startups at the 15th TOP 100 Swiss Startup Award!

MYNERVA and Apersys, current and alumni Wyss Zurich startups, joining the top 8% of over 1,500 global applicants selected for the world-class accelerator MassChallange.

project MYNERVA and Apersys AG were recently selected to join the Venture Leaders Medtech 2024. They will travel with 8 other leaders to Boston from 4 to 6 November 2024.

An interdisciplinary group of surgeons, engineers, and biologists from the Wyss Zurich Translational Center, University of Zurich, and ETH Zurich, has established a new strategy that allows removal of fat from fatty human livers outside the body.

For the successful transplant, the multidisciplinary research team treated the damaged liver outside the body in a machine for three days and then implanted the recovered organ into the patient.

The multidisciplinary research team of the Wyss Zurich project Liver4Life has succeeded in a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient. One year later, the patient is doing well.